文献速递脊柱关节炎

在银屑病关节炎常规实践队列中定义银屑病关节炎疾病活动度评分(PASDAS)的最小重要变化(MIC)和有意义变化值(MCV)

Defining the minimal important change (MIC) and meaningful change value (MCV) for the Psoriatic Arthritis Disease Activity Score (PASDAS) in a routine practice cohort of patients with psoriatic arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

研究基于544例银屑病关节炎患者的常规实践数据,采用线性回归的锚定法确定PASDAS的MIC和MCV,并计算测量标准误(s.e.m.)。总体MIC为0.67(95%CI:0.55,0.79),总体MCV为1.34(95%CI:1.21,1.46),s.e.m.为0.81。作者认为MIC有助于医生结合患者视角解读疾病活动度,MCV可能有助于PASDAS在临床试验中的应用。

要点

  • PASDAS总体MIC为0.67(95%CI:0.55,0.79),总体MCV为1.34(95%CI:1.21,1.46)。
  • 改善方向MIC为0.65(95%CI:0.46,0.83),恶化方向MIC为0.71(95%CI:0.49,0.93)。
  • 改善方向MCV为1.29(95%CI:1.11,1.48),恶化方向MCV为1.42(95%CI:1.19,1.64)。

核心结论

  • PASDAS的MIC有助于医生结合患者视角解读疾病活动度,MCV可能有助于PASDAS在银屑病关节炎临床试验中的应用。

研究设计与样本

  • 研究分析了544例银屑病关节炎患者的常规实践数据,采用基于线性回归的锚定法确定PASDAS的MIC和MCV。
  • 锚定问题询问患者自上次就诊以来健康状况是否变化,采用7点Likert量表(范围从极大改善到极大恶化)。
  • 通过期间相关矩阵分析确定测量标准误(s.e.m.)。

主要发现

  • PASDAS总体MIC为0.67(95%CI:0.55,0.79),总体MCV为1.34(95%CI:1.21,1.46)。
  • 改善方向MIC为0.65(95%CI:0.46,0.83),恶化方向MIC为0.71(95%CI:0.49,0.93)。
  • 改善方向MCV为1.29(95%CI:1.11,1.48),恶化方向MCV为1.42(95%CI:1.19,1.64)。
  • 测量标准误(s.e.m.)为0.81。

关键数值与推荐

  • PASDAS总体MIC为0.67(95%CI:0.55,0.79),总体MCV为1.34(95%CI:1.21,1.46)。
  • 改善方向MIC为0.65(95%CI:0.46,0.83),恶化方向MIC为0.71(95%CI:0.49,0.93)。
  • 改善方向MCV为1.29(95%CI:1.11,1.48),恶化方向MCV为1.42(95%CI:1.19,1.64)。
  • 测量标准误(s.e.m.)为0.81。

临床怎么用

  • 作者认为MIC是医生治疗银屑病关节炎患者的一种工具,使其能够结合患者视角解读疾病活动度。
  • 作者认为MCV可能有助于PASDAS在银屑病关节炎临床试验中的应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the study was to determine the Minimal Important Change (MIC) values and Meaningful Change (MCV) values for the Psoriatic Arthritis Disease Activity Score (PASDAS) and the Standard Error of Measurement (s.e.m.) of the PASDAS. METHODS: The routine practice data for 544 patients with PsA was available for analysis. An anchor-based method using linear regression analyses was used to determine the MICs and MCVs for the PASDAS. With this anchor-based method, we compared changes in the PASDAS score with an external reference (anchor). The anchor question inquired whether the patient's well-being had changed since their previous visit. It consisted of a 7-point Likert scale (range: very much improved to very much deteriorated). Interperiod correlation matrix analysis was performed to determine the s.e.m. RESULTS: The overall MIC and MCV for the PASDAS were 0.67 (95% CI: 0.55, 0.79) and 1.34 (95% CI: 1.21, 1.46), respectively. Results for improvement and deterioration were 0.65 (95% CI: 0.46, 0.83) and 0.71 (95% CI: 0.49, 0.93) for the MIC, respectively, and 1.29 (95% CI: 1.11, 1.48) and 1.42 (95% CI: 1.19, 1.64) for the MCV, respectively. The s.e.m. was determined at 0.81. CONCLUSION: The MIC for the PASDAS is a tool for physicians treating patients with PsA enabling them to give context to the patient's perspective of disease activity, while the MCV might aid the use of the PASDAS in PsA clinical trials.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Mulder MLM, Bertram AM, Wenink MH, et al. Defining the minimal important change (MIC) and meaningful change value (MCV) for the Psoriatic Arthritis Disease Activity Score (PASDAS) in a routine practice cohort of patients with psoriatic arthritis. Rheumatology (Oxford). 2022. PMID: 35025996. doi:10.1093/rheumatology/keac025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。